What does Sinocelltech Group Limited do?

Sinocelltech Group Limited (688520.SS) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 688520.SS's market cap?

Sinocelltech Group Limited (688520.SS) has a market capitalization of approximately $16.89 billion, as of July 23, 2026, based on the most recent share price and shares outstanding.

Does 688520.SS pay a dividend?

No — Sinocelltech Group Limited (688520.SS) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Is 688520.SS profitable?

Sinocelltech Group Limited (688520.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

688520.SS

Sinocelltech Group Limited

SHH·Biotechnology · Healthcare

¥35.91¥0.69−1.89%

Market cap¥16.89B·Market closed·Jul 23 5:19 AM UTC

Price Chart

¥35.91−¥0.69 (−1.89%)today

−42.59%CAGR −10.51%

Select date range

FromTo

Jun 22, 2020Jul 23, 2021 → Jul 23, 2026· 5.0 yrsJul 23, 2026

Key Metrics

688520.SS does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)¥0.03

P/E Ratio (FWD)1,197.00

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateAug 26

Last Report DateApr 30

Reported vs Estimate−¥0.41

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥1.36B

Net Income−¥792.75M

Net Margin−58.2%

Operating Cash Flow−¥260.27M

Capital Expenditures¥254.54M

Free Cash Flow−¥514.81M

Return on Equity−1,119.3%

Return on Invested Capital−3.2%

Net Debt¥2.35B

Analyst Estimates

PRO

Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.

Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 688520.SS and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 688520.SS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 688520.SS and 80,000+ other tickers.

About Sinocelltech Group Limited

Sinocelltech Group Limited is a Beijing-based biotechnology enterprise. The company's primary focus lies in pioneering and refining the technologies required for both the creation and large-scale production of vital biological agents, specifically recombinant proteins, monoclonal antibodies, and vaccines, throughout China.

CEO: Liangzhi Xie
Sector: Healthcare
Industry: Biotechnology
Exchange: SHH
Employees: 2,200
Website: www.sinocelltech.com

Peers

Peers Tab

688266.SS

Suzhou Zelgen Biopharmaceuticals Co., Ltd.

Cap

¥38.1B

300204.SZ

Staidson (Beijing) BioPharmaceuticals Co., Ltd.

Cap

¥11.7B

603233.SS

DaShenLin Pharmaceutical Group Co., Ltd.

Cap

¥21.4B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 688520.SS

What does Sinocelltech Group Limited do?: Sinocelltech Group Limited (688520.SS) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 688520.SS's market cap?: Sinocelltech Group Limited (688520.SS) has a market capitalization of approximately $16.89 billion, as of July 23, 2026, based on the most recent share price and shares outstanding.
Does 688520.SS pay a dividend?: No — Sinocelltech Group Limited (688520.SS) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is 688520.SS profitable?: Sinocelltech Group Limited (688520.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.